At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,398 enrolled
Drug / intervention
MiStent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Randomized Study of the MiStent Sirolimus Eluting Absorbable Polymer Stent System (MiStent SES) for Revascularization of Coronary Arteries
In Brief
A clinical study evaluating MiStent and XIENCE EES for Coronary Stenosis. Completed, enrolled 1,398 participants across 20 sites in 4 countries.
Detailed Summary
The primary objective of this study is to compare the performance of MISTENT to that of XIENCE in an all-comers patient population with symptomatic ischemic heart disease. The patients will be followed through 3 years for major clinical events.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Stenosis
CountriesFrance, Germany, Netherlands, Poland
CollaboratorsMicell Technologies, Stentys
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartMar 2015
Primary CompletionJan 2017
Study CompletionFeb 2021
TodayJul 2026
First PostedMar 11, 2015
Enrollment StartMar 20, 2015
Primary CompletionJan 31, 2017
Study CompletionFeb 4, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 11.3 years ago
Interventions
MiStentdevice
Percutaneous Coronary Intervention
XIENCE EESdevice
Percutaneous Coronary Intervention